Lupin’s Mandideep Unit-II facility receives EIR

Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) after closure of the USFDA inspection of its Mandideep Unit-II facility, classifying the inspection as voluntary action indicated. The inspection at the facility was carried out by the USFDA between November 26, 2018 and December 4, 2018.

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.